James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 100,000 shares at $25.01 ($2.5M) on 2023-04-28, disclosed to the SEC on 2023-05-02.
Open-market sale of $2.5M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.01 | 40,000 | $1.0M | 39.9% |
| 2 | $25.01 | 40,000 | $1.0M | 39.9% |
| 3 | $25.04 | 7,640 | $191K | 7.6% |
| 4 | $25.04 | 7,640 | $191K | 7.6% |
| 5 | $25.91 | 2,360 | $61K | 2.4% |
| 6 | $25.91 | 2,360 |
| $61K |
| 2.4% |
| Total | $25.06 avg | 100,000 | $2.5M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |